Weekly Research Analysts’ Ratings Updates for CME Group (CME)

Several brokerages have updated their recommendations and price targets on shares of CME Group (NASDAQ: CME) in the last few weeks:

• 1/22/2026 – CME Group had its price target raised by analysts at JPMorgan Chase & Co. from $256.00 to $262.00. They now have an “underweight” rating on the stock.
• 1/15/2026 – CME Group had its price target lowered by analysts at Morgan Stanley from $320.00 to $319.00. They now have an “overweight” rating on the stock.
• 1/14/2026 – CME Group was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating.
• 1/14/2026 – CME Group had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $265.00 to $264.00. They now have a “sell” rating on the stock.
• 1/14/2026 – CME Group was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $305.00 price target on the stock, up previously from $290.00.
• 1/12/2026 – CME Group had its price target lowered by analysts at Jefferies Financial Group Inc. from $304.00 to $302.00. They now have a “buy” rating on the stock.
• 1/6/2026 – CME Group had its “neutral” rating reaffirmed by analysts at UBS Group AG.
• 1/5/2026 – CME Group had its price target raised by analysts at Raymond James Financial, Inc. from $307.00 to $311.00. They now have an “outperform” rating on the stock.
• 12/29/2025 – CME Group had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – CME Group had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – CME Group had its price target raised by analysts at Morgan Stanley from $314.00 to $320.00. They now have an “overweight” rating on the stock.
• 12/17/2025 – CME Group had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $310.00 to $318.00. They now have a “buy” rating on the stock.
• 12/12/2025 – CME Group had its price target raised by analysts at Barclays PLC from $280.00 to $304.00. They now have an “equal weight” rating on the stock.
• 12/10/2025 – CME Group had its price target raised by analysts at Bank of America Corporation from $201.00 to $209.00.
• 12/5/2025 – CME Group had its price target raised by analysts at Royal Bank Of Canada from $282.00 to $295.00. They now have a “sector perform” rating on the stock.
• 12/4/2025 – CME Group had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a “sell” rating on the stock.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is 48.45%.

Insider Activity at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company’s stock.

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.